Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Award
Common Stock
2014-02-28+16,659→ 74,659 total - Award
Employee Stock Option (Right to Buy)
2014-02-28+64,625→ 64,625 totalExercise: $1.82Exp: 2024-02-28→ Common Stock (64,625 underlying)
Footnotes (2)
- [F1]Vests in full on February 28, 2015.
- [F2]25% excercisable on the one year anniversary of the date of grant with the balance vesting quarterly over the remaining three years.